Exagen Future Growth

How is Exagen forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

[object Object] Score

2/6

Future Growth Score 2/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


16.9%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqGM:XGN - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202465-34-29-194
12/31/202351-42-37-285
12/31/202242-46-44-375
9/30/202245-40-37-32N/A
6/30/202243-39-36-31N/A
3/31/202248-31-28-25N/A
12/31/202148-27-23-20N/A
9/30/202148-23-19-18N/A
6/30/202147-20-16-15N/A
3/31/202143-17-16-15N/A
12/31/202042-17-15-14N/A
9/30/202040-17-15-14N/A
6/30/202039-29-14-14N/A
3/31/202041-31-11-11N/A
12/31/201940-30-10-10N/A
9/30/201940-31-8-8N/A
6/30/201938-18-9-8N/A
3/31/201935-18-8-8N/A
12/31/201832-18-9-9N/A
12/31/201727-33-12-11N/A
12/31/201518-21N/A-12N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: XGN is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: XGN is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: XGN is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: XGN's revenue (23.1% per year) is forecast to grow faster than the US market (6.9% per year).

High Growth Revenue: XGN's revenue (23.1% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if XGN's Return on Equity is forecast to be high in 3 years time


Discover growth companies